GlassScriptPhysician profile
Barbara Cruikshank
NPI 1053463075
$1,468.11
in general payments reported to CMS, 2019-2025
21 companies · $57.63 in 2025
The $57.63 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $50.40 · 2021: $124 · 2022: $15.51 · 2025: $57.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $283.60 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $252.25 | 2019-2021 | |
| Astellas Pharma US INC | $245.51 | 2019 | |
| Braintree Laboratories, INC. | $137.44 | 2019 | |
| Amgen INC. | $126.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $73.57 | 2019 | |
| Abbvie INC. | $64.12 | 2019-2022 | |
| Pfizer INC. | $39.09 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.55 | 2019 | |
| Avanir Pharmaceuticals, INC. | $31.29 | 2019 | |
| Medtronic USA, INC. | $24.11 | 2019 | |
| Sebela Pharmaceuticals INC. | $22.69 | 2019 | |
| Antares Pharma, INC. | $21.22 | 2019 | |
| Hologic Sales and Service, LLC | $16.18 | 2019 | |
| Allergan, INC. | $15.52 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.41 | 2019 | |
| Amarin Pharma, INC. | $14.52 | 2019 | |
| Optinose US, INC. | $13.93 | 2019 | |
| Assertio Therapeutics, INC. | $13.71 | 2019 | |
| Aytu Biopharma, INC. | $12.89 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Cruikshank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.